Detalhe da pesquisa
1.
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
Mov Disord;
35(5): 833-844, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32073681
2.
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.
Ann Clin Transl Neurol;
5(12): 1460-1477, 2018 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30564614
3.
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.
PLoS One;
12(5): e0175674, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28520803
4.
Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.
Ann Clin Transl Neurol;
2(5): 534-47, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26000325